The poor prognosis of pancreatic cancer relates mainly to its delayed diagn
osis. It has been repeatedly shown that earlier diagnosis of pancreatic can
cer is associated with a better outcome. Molecular diagnostic methods (main
ly detection of K-ms mutations in pure pancreatic or duodenal juice, on spe
cimens obtained by percutaneous fine-needle aspirations or in stool specime
ns) can achieve earlier diagnosis in selected subgroups of patients, such a
s patients,vith chronic pancreatitis (especially hereditary), adults with r
ecent onset of non-insulin-dependent diabetes mellitus and patients with so
me inherited disorders that predispose to the development of pancreatic can
cer. There is increasing evidence that pancreatic carcinogenesis is a multi
-step phenomenon, Screening procedures for precursor lesions in these selec
ted subgroups of patients may reduce the incidence and mortality from pancr
eatic cancer.